Morocco’s National Fund for Social Security Organizations (CNOPS) is facing a financial squeeze, with reserves falling from 11 billion dirhams in 2020 to just 4 billion today.
MP Fatima Tamni said in a written question to the Ministry of Health and Social Protection that unchecked profits by pharmaceutical companies are a major culprit.
Tamni, a member of the Federation of the Democratic Left, has accused both local and international drug firms of exploiting loopholes in Morocco’s pricing system to make “unjustified” profits, reportedly totaling over MAD 1.5 billion per year.
She points to imported medicines undervalued at customs and weak enforcement of the government’s price regulations as key drivers of this imbalance.
These inflated profits are not just numbers on paper, Tamni says that they directly hit citizens, making medicines harder to afford and threatening fair access to treatment.
The parliamentarian demanded urgent action from the government, asking about immediate measures to protect citizens’ purchasing power and safeguard the sustainability of health insurance.
She also questioned when a full review of the drug pricing system will be launched to ensure transparency, fairness, and competition.
Tamni’s warning comes amid rising public concern over healthcare costs in Morocco. The financial strain on CNOPS is seen as a wake-up call for policymakers to tighten oversight of pharmaceutical companies and enforce pricing rules more strictly.
The lawmaker urged the ministry to assess the total profits made by companies from these irregularities and to act against practices that undermine public trust.
With health insurance reserves dwindling, millions of Moroccans who rely on CNOPS could face higher costs and reduced access to medicines if reforms are not implemented quickly.
add your comment
Terms of publication : Not to offend the writer, people, sacred things, or attack religions or the divine self, and refrain from racist incitement and insults.